Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics.
The effects of high thoracic epidural anesthesia (TEA) on cardiac sympathetic nerve activity, myocardial blood flow and metabolism, and central hemodynamics were studied in 20 patients undergoing coronary artery bypass grafting (CABG). In 10 of the patients, TEA (T1-5 block) was used as an adjunct to a standardized fentanyl-nitrous oxide anesthesia. Hemodynamic measurements and blood sampling were performed after induction of anesthesia but prior to skin incision and after sternotomy. Assessment of total and cardiac sympathetic activity was performed by means of the norepinephrine kinetic approach. Prior to surgery, mean arterial pressure (MAP), great cardiac vein flow (GCVF), and regional myocardial oxygen consumption (Reg-MVO2) were lower in the TEA group compared to the control group. During sternotomy there was a pronounced increase in cardiac norepinephrine spillover, MAP, systemic vascular resistance index (SVRI), pulmonary capillary wedge pressure (PCWP), GCVF, and Reg-MVO2 in the control group. These changes were clearly attenuated in the TEA group. None of the patients in the TEA group had metabolic (lactate) or electrocardiographic signs of myocardial ischemia. Three patients in the control group had indices of myocardial ischemia prior to and/or during surgery. We conclude that TEA attenuates the surgically mediated sympathetic stress response to sternotomy, thereby preventing the increase in myocardial oxygen demand in the pre-bypass period without jeopardizing myocardial perfusion.
Department of Anesthesiology and Intensive Care, University of Göteborg, Sahlgren's Hospital, Sweden.
K
K
Kirnö
P
P
Friberg
A
A
Grzegorczyk
I
I
Milocco
S E
SE
Ricksten
S
S
Lundin
D000767:Anesthesia, Epidural; D001026:Coronary Artery Bypass / Q000009:adverse effects; D003326:Coronary Circulation / Q000187:drug effects*; D005283:Fentanyl; D006321:Heart / Q000187:drug effects* / Q000294:innervation*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D009206:Myocardium / Q000378:metabolism*; D009609:Nitrous Oxide; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism; D013312:Stress, Physiological / Q000209:etiology / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014316:Tritium
D007773:Lactates; D014316:Tritium; D019344:Lactic Acid; D009609:Nitrous Oxide; D005283:Fentanyl; D009638:Norepinephrine